These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26984923)

  • 1. Are We at the End of the Bone Morphogenetic Protein Era? Commentary on an article by Diyar Delawi, MD, PhD, et al.: "OP-1 Compared with Iliac Crest Autograft in Instrumented Posterolateral Fusion. A Randomized, Multicenter Non-Inferiority Trial".
    Coe JD
    J Bone Joint Surg Am; 2016 Mar; 98(6):e23. PubMed ID: 26984923
    [No Abstract]   [Full Text] [Related]  

  • 2. OP-1 Compared with Iliac Crest Autograft in Instrumented Posterolateral Fusion: A Randomized, Multicenter Non-Inferiority Trial.
    Delawi D; Jacobs W; van Susante JL; Rillardon L; Prestamburgo D; Specchia N; Gay E; Verschoor N; Garcia-Fernandez C; Guerado E; Quarles van Ufford H; Kruyt MC; Dhert WJ; Oner FC
    J Bone Joint Surg Am; 2016 Mar; 98(6):441-8. PubMed ID: 26984911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Vaccaro AR, Patel T, Fischgrund J, et al. A pilot study evaluating safety and efficacy of OP-1 putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 2004;29:1885-92.
    Bagaria V
    Spine (Phila Pa 1976); 2006 Apr; 31(7):851; author reply 851-2. PubMed ID: 16582862
    [No Abstract]   [Full Text] [Related]  

  • 4. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study.
    Vaccaro AR; Lawrence JP; Patel T; Katz LD; Anderson DG; Fischgrund JS; Krop J; Fehlings MG; Wong D
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2850-62. PubMed ID: 19092614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2005 Sep; 14(7):623-9. PubMed ID: 15672240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
    Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
    Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
    Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
    J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can preoperative radiographic parameters be used to predict fusion in non-instrumented posterolateral fusion for degenerative spondylolisthesis?
    Agabegi SS; Majid K; Fischgrund JS; Vaccaro AR; Patel T
    Spine (Phila Pa 1976); 2011 Dec; 36(26):E1709-14. PubMed ID: 21508884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the use of rhBMP-7 versus iliac crest autograft in single-level lumbar fusion: a meta-analysis of randomized controlled trials.
    Ye F; Zeng Z; Wang J; Liu H; Wang H; Zheng Z
    J Bone Miner Metab; 2018 Jan; 36(1):119-127. PubMed ID: 28342094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, controlled, multicenter study of osteogenic protein-1 in instrumented posterolateral fusions: report on safety and feasibility.
    Delawi D; Dhert WJ; Rillardon L; Gay E; Prestamburgo D; Garcia-Fernandez C; Guerado E; Specchia N; Van Susante JL; Verschoor N; van Ufford HM; Oner FC
    Spine (Phila Pa 1976); 2010 May; 35(12):1185-91. PubMed ID: 20445470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
    Park DK; Kim SS; Thakur N; Boden SD
    Spine (Phila Pa 1976); 2013 May; 38(12):E738-47. PubMed ID: 23474598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up.
    Dai LY; Jiang LS
    Spine (Phila Pa 1976); 2008 May; 33(12):1299-304. PubMed ID: 18496340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rhBMP in lumber fusion for lumbar spondylolisthesis: A systematic review and meta-analysis.
    Han PF; Chen TY; Zhang ZL; Li XD; Li PC; Wei L; Lü Z; Wei XC
    Chin J Traumatol; 2019 Feb; 22(1):51-58. PubMed ID: 30745112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment.
    Kanayama M; Hashimoto T; Shigenobu K; Yamane S; Bauer TW; Togawa D
    Spine (Phila Pa 1976); 2006 May; 31(10):1067-74. PubMed ID: 16648739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerating autograft maturation in instrumented posterolateral lumbar spinal fusions without donor site morbidity.
    Rogozinski A; Rogozinski C; Cloud G
    Orthopedics; 2009 Nov; 32(11):809. PubMed ID: 19902899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
    Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
    J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
    Mummaneni PV; Pan J; Haid RW; Rodts GE
    J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uni- and bilateral instrumented posterolateral fusion of the lumbar spine with local bone grafting: a prospective study with a 2-year follow-up.
    Ohtori S; Koshi T; Suzuki M; Takaso M; Yamashita M; Yamauchi K; Inoue G; Orita S; Eguchi Y; Ochiai N; Kishida S; Kuniyoshi K; Aoki Y; Nakamura J; Ishikawa T; Arai G; Miyagi M; Kamoda H; Suzuki M; Furuya T; Toyone T; Takahashi K
    Spine (Phila Pa 1976); 2011 Dec; 36(26):E1744-8. PubMed ID: 21544013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 2006; 31:2534-40.
    Gill JB
    Spine (Phila Pa 1976); 2007 Mar; 32(6):708; author reply 708. PubMed ID: 17413480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.